Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences — an occurrence often referred to as “chemobrain” — that may compromise the quality of life of a proportion of cancer survivors. Now, new research demonstrates that treatment with a single chemotherapeutic agent, 5-fluorouracil, by itself is sufficient to cause a syndrome of delayed degeneration in the central nervous system.